Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

2.

Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy.

Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, Youle M.

AIDS. 2004 Jul 23;18(11):1549-60.

PMID:
15238773
4.

Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study.

Osio M, Muscia F, Zampini L, Nascimbene C, Mailland E, Cargnel A, Mariani C.

J Peripher Nerv Syst. 2006 Mar;11(1):72-6.

PMID:
16519785
6.

Long-term effect of acetyl-L-carnitine for antiretroviral toxic neuropathy.

Herzmann C, Johnson MA, Youle M.

HIV Clin Trials. 2005 Nov-Dec;6(6):344-50.

PMID:
16566084
7.

Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.

Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.

Clin Ther. 2007 Oct;29(10):2179-93. Erratum in: Clin Ther. 2009 Mar;31(3):677.

PMID:
18042474
8.

Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.

Scarpini E, Sacilotto G, Baron P, Cusini M, Scarlato G.

J Peripher Nerv Syst. 1997;2(3):250-2.

PMID:
10975731
9.

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.

McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA, Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, Smith ME, Shriver S, Millar L, Clifford DB, Karalnik IJ.

Neurology. 2000 Mar 14;54(5):1080-8. Erratum in: Neurology 2000 Jul 13;55(1):162.

PMID:
10720278
10.

Pharmacokinetics of acetyl-L-carnitine given in single or multiple doses to HIV-1 Infected patients with toxic peripheral polyneuropathy.

Herzmann C, Whiting SJ, Thomas M, Byrne P, Johnson MA, Youle M.

Open AIDS J. 2008;2:39-42. doi: 10.2174/1874613600802010039. Epub 2008 Jun 4.

11.

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.

Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF.

Neurology. 1996 Sep;47(3):705-11.

PMID:
8797468
12.

A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy.

Estanislao L, Carter K, McArthur J, Olney R, Simpson D; Lidoderm-HIV Neuropathy Group.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1584-6.

PMID:
15577414
13.

A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.

Beaulieu AD, Peloso P, Bensen W, Clark AJ, Watson CP, Gardner-Nix J, Thomson G, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC.

Clin Ther. 2007 Jan;29(1):49-60.

PMID:
17379046
14.

A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain.

Bannwarth B, Allaert FA, Avouac B, Rossignol M, Rozenberg S, Valat JP.

J Rheumatol. 2005 Jun;32(6):1114-7.

PMID:
15940776
15.
16.

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial.

Boureau F, Legallicier P, Kabir-Ahmadi M.

Pain. 2003 Jul;104(1-2):323-31.

PMID:
12855342
17.

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

Thal LJ, Calvani M, Amato A, Carta A.

Neurology. 2000 Sep 26;55(6):805-10.

PMID:
10994000
20.

Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Youle M.

CNS Drugs. 2007;21 Suppl 1:25-30; discussion 45-6. Review.

PMID:
17696590

Supplemental Content

Support Center